Mesoblast Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Mesoblast Limited (MESO) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2018
Current Assets
Cash and Cash Equivalents0.160.060.070.060.140.130.04
Cash & Short-Term Investments0.160.060.070.060.140.130.04
Accounts Receivable0.010.000.010.000.000.000.05
Inventory0.020.000.000.000.000.000.00
Other Current Assets0.010.020.000.000.000.000.00
Total Current Assets0.200.090.080.070.150.140.10
Non-Current Assets
Property, Plant & Equipment (Net)0.010.000.010.010.010.010.00
Long-Term Investments0.000.000.000.000.000.000.00
Goodwill0.130.130.130.130.130.000.00
Intangible Assets0.440.440.440.440.450.000.00
Other Non-Current Assets0.000.000.000.000.000.010.00
Total Non-Current Assets0.580.580.650.590.590.600.59
Total Assets0.780.670.730.660.740.730.69
Current Liabilities
Accounts Payable0.020.010.020.020.020.020.02
Short-Term Debt0.060.010.010.010.050.000.00
Current Portion of Long-Term Debt0.050.010.010.010.050.000.00
Accrued Liabilities0.010.010.000.000.000.000.00
Other Current Liabilities0.030.000.010.021.160.000.00
Total Current Liabilities0.100.070.040.051.260.090.02
Non-Current Liabilities
Long-Term Debt0.070.100.110.090.050.060.06
Other Non-Current Liabilities0.010.010.020.020.071.100.00
Total Non-Current Liabilities0.080.120.130.110.131.190.12
Total Liabilities0.190.190.170.171.391.280.15
Stockholders' Equity
Common Stock1.511.311.251.171.160.000.00
Retained Earnings-1.01-0.91-0.82-0.74-0.65-0.55-0.38
Accumulated Other Comprehensive Income0.10-0.83-0.750.070.070.000.04
Shares Outstanding1.281.140.860.690.000.000.00
Total Stockholders' Equity0.600.480.500.50-0.65-0.550.55
Total Liabilities & Equity0.780.670.730.660.740.730.69